BioHealth News Archive
Medcura Expands its Senior Leadership Team and Appoints Leading Neurosurgeon Dr. Kenneth Renkens as Chief Medical Officer · BioBuzz
RIVERDALE, Md., April 26, 2022 /PRNewswire/ — Medcura, Inc., a commercial-stage medical device company, today announced the expansion of its senior management team to include Dr. Kenneth Renkens as its…
Read MoreEmmes and Casimir Announce Research About a Novel, Home-Based Assessment for Duchenne Muscular Dystrophy | Emmes
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that Casimir’s research…
Read MoreThe ARPA-H (Health) Headquarters: Where Will It Be, and Should I Care?
The medical science publication Stat just published an article about Congressional interest in the location of ARPA-H headquarters, the new $6 billion effort to fund…
Read MoreRaymond Blanchard, Associate Director of IP & Licensing with QIAGEN, visits BioTalk
QIAGEN Associate Director of IP & Licensing, Raymond Blanchard, chats with Rich Bendis on BioTalk to discuss innovation, intellectual property and having a large…
Read More500,000-square-foot life science campus coming to Jefferson Technology Park
Apr. 22—Construction will start this September on a 500,000-square-foot life science campus in Frederick County's Jefferson Technology Park that the developer says will be…
Read MoreAURP to Host 2022 BIO Health Caucus on “Growing Bio Clusters and Bio Companies” June 12-13 in San Diego – Digital Journal
TUCSON, AZ / ACCESSWIRE / April 20, 2022 / AURP, the leading non-profit representing research parks, innovation districts and regional technology clusters, today announced…
Read MoreInitial Results from Novavax’ COVID-19-Influenza Vaccine Trial are First to Show Feasibility of Combination Vaccine
Phase 1/2 clinical trial of COVID-19-Influenza combination vaccine candidate indicates vaccine is well-tolerated and immunogenic Data from this combination trial will inform planned Phase…
Read MoreDon’t Miss Out! Pitching To Get Attention Workshop
Join ETC and Squadra Ventures on May 18, 2022 from 5:00 pm - 7:00 pm at Monument City Brewing for the second Open Mic…
Read MoreMaryland Life Science Advisory Board Welcomes New Members · BioBuzz
The Life Sciences Advisory Board added three new members, Ellington West of Sonavi Labs, Michael Weingarten of the National Cancer Institute, and GlaxoSmithKline’s KaShauna…
Read MoreAurinia Announces Year-Two Commitment to Patient Navigation Grant Program to Address Barriers for Individuals Living with Lupus and Lupus Nephritis
– Company seeks proposals to create and sustain community-focused programs to support underserved populations with these conditions – VICTORIA, British Columbia & ROCKVILLE, Md.--(BUSINESS…
Read MoreKite Receives U.S. FDA Approval of New State-of-the-Art CAR T-Cell Therapy Manufacturing Facility in Maryland
April 19, 2022 12:00 UTC -- Kite’s Global CAR T-Cell Therapy Manufacturing Network Increasing Capacity by 50% to Meet Patient Demand for New…
Read MoreBiden’s Biotech Moonshot Has The Money. Now Cities Want It In Their Backyard
Cities and states jockeying for position in the race for biotech dollars and talent have their sights set on a whale that comes along once in a…
Read MoreJoin BLUE KNIGHT™ this June: Accelerating preparedness together
Did you hear? Our second BLUE KNIGHT™ Symposium will take place June 9, 2022, and we’re excited to present your first chance to register!…
Read MoreMIMETAS participates in €325 million Oncode-PACT initiative to accelerate and improve oncology drug development
LEIDEN, The Netherlands, April 14, 2022 - MIMETAS, a global leader in organ-on-chip-based disease models, is a partner in the Oncode-PACT initiative that has…
Read MoreWebcast on Value Analysis at Children’s National | April 20 at 1:30p EST
Please join the inaugural webcast “Tell Me Something I Don’t Know,” hosted by Children’s National Hospital (CNH) Innovation Ventures and the National Capital Consortium…
Read More